Target intelligence / Profile preview

tRNA (guanine-N7)-methyltransferase non-catalytic subunit WDR4 (WDR4)

Target
WDR4
Molecular classification
Enzyme auxiliary subunit (methyltransferase complex cofactor), WD repeat-containing protein, Other
01

Overview

tRNA (guanine-N7)-methyltransferase non-catalytic subunit WDR4 (WDR4) is the non-catalytic, regulatory subunit of the METTL1-WDR4 complex that mediates methylation of guanine at the N7 position (m^7G) at position 46 in tRNAs in humans[1][2][3]. The modification is essential for tRNA stability and efficient protein synthesis. WDR4 is a WD repeat-containing protein that acts as a molecular scaffold—facilitating correct folding, efficient cofactor (SAM) binding, and tRNA substrate recognition by METTL1. Loss-of-function mutations in WDR4 result in reduced m^7G46 modification and have been linked to disorders such as primordial dwarfism and brain malformation; dysregulation in this complex is also associated with cancer. WDR4 itself does not catalyze methyl transfer but is required for the enzymatic activity of the complex and maintaining METTL1 stability[1][2][3]. No approved drugs are known to target WDR4 directly; however, its essential role in RNA modification and human disease suggests it may become a relevant target for future drug discovery[1][3].

Other names
WD repeat domain 4WD repeat-containing protein 4protein Wuho homologTRM82TRMT82hWHGAMOS6MIGSBWD repeat domain 4 METTL1 scaffold proteinTRM82 tRNA methyltransferase 82 homolog (S. cerevisiae)
02

Mechanism of action

Scaffold/co-factor for tRNA methyltransferase activity (enables METTL1's methylation of tRNA at guanine N7 position)

03

Biological functions

RNA modificationtRNA methylationRegulation of gene expressionCell proliferationOther
04

Disease associations

CancerNeurodevelopmental disorder (e.g., brain malformation, primordial dwarfism)Other
05

Safety considerations

Loss of function mutations lead to developmental disorders (including primordial dwarfism and brain abnormalities)Potential impact on normal cell growth if targeted for therapy, as WDR4 is essential for cellular viability and tRNA stability
06

Biomarkers

Loss-of-function or mutant WDR4 as a biomarker for developmental brain malformations and certain cancers

Beyond the preview

Go deeper on tRNA (guanine-N7)-methyltransferase non-catalytic subunit WDR4 (WDR4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tRNA (guanine-N7)-methyltransferase non-catalytic subunit WDR4 (WDR4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call